Skip to content

Investigation of pathophysiology of refractory peptic ulcers

Investigation of pathophysiology of refractory peptic ulcers - pathophysiology of refractory peptic ulcers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027530
Enrollment
30
Registered
2017-05-29
Start date
2017-05-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory peptic ulcers

Interventions

None listed

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with peptic ulcer who are refractory to medical treatment. Patients who was planned esophagogastroduodenoscopy for following up peptic ulcers. Patients who understand aim of this study and can give informed consent.

Exclusion criteria

Exclusion criteria: Pregnant women Patients who underwent chemotherapy and opioid treatment for cancer.

Design outcomes

Primary

MeasureTime frame
pH of upper gastrointestinal tract

Secondary

MeasureTime frame
gene polymorphism of CYP2C19

Countries

Japan

Contacts

Public ContactTatsuhiro Masaoka

Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine

masaoka@keio.jp03-5363-3790

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026